BMS 181100
Alternative Names: BMY 14802; BMY 14802 1; MJ 14802Latest Information Update: 21 Sep 2000
At a glance
- Originator Bristol-Myers Squibb
- Class Anti-infectives; Antiallergics; Antiasthmatics; Antipsychotics; Ischaemic heart disorder therapies
- Mechanism of Action 5-HT1A serotonin receptor agonists; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders